Previous Article | Next Article ![]()
Infection and Immunity, April 2000, p. 1806-1814, Vol. 68, No. 4
Department of Preventive Medicine and AIDS
Research1 and Department of
Bacteriology,2 Institute of Tropical Medicine,
Nagasaki University, Nagasaki, Japan; Department of
Inflammatory Diseases, Boehringer Ingelheim Pharmaceuticals,
Incorporated, Ridgefield, Connecticut3; and
Ernst Boehringer Institut, Vienna, Austria4
Received 22 September 1999/Returned for modification 19 November
1999/Accepted 28 December 1999
Interactions between leukocytes and epithelial cells may play a key
role in Helicobacter pylori-associated gastric mucosal inflammation. This process is mediated by various cell adhesion molecules. The present study examined the molecular mechanisms leading
to H. pylori-induced epithelial cell intercellular adhesion molecule-1 (ICAM-1; also called CD54) expression. Coculture of epithelial cells with cytotoxin-associated gene pathogenicity island-positive (cag PAI+) H. pylori strains, but not with a cag PAI Several lines of evidence implicate
Helicobacter pylori in the pathogenesis of active chronic
gastritis, peptic ulcer disease, gastric carcinoma, and gastric B-cell
lymphoma, even though most H. pylori infections are
asymptomatic (7, 29, 31). Although the exact mechanisms by
which H. pylori infection results in gastroduodenal pathology are unclear, current opinion holds that H. pylori
can induce an acute inflammatory reaction consisting of leukocyte infiltration and epithelium damage (4, 14). However, because H. pylori generally adheres to gastric epithelial cells
without invading the epithelium, it is presumed that an interaction
between bacteria and host epithelial cells may initiate H. pylori-induced inflammation. Because of the strong inflammatory
response to H. pylori infections, the role of inflammatory
cytokines was investigated. It was shown that mucosal biopsy specimens
from patients with H. pylori infections contain
significantly elevated levels of interleukin-1 Cell-cell interactions play an important and probably central role in a
large number of immunological processes in physiological and
pathological conditions. These interactions are at least partially mediated by various cell adhesion molecules. Expression of cell adhesion molecules on gastric epithelial cells may participate in
leukocyte homing and epithelial-cell adhesion in H. pylori-associated mucosal inflammation. In the context of H. pylori infection, the production of chemoattractive cytokines and
cell adhesion molecules could provide a means of recruiting and
retaining inflammatory cells within the gastric epithelial layer,
contributing to H. pylori-mediated tissue injury.
In this study, we show that gastric epithelial cells have the ability
to initiate changes associated with inflammation through the
upregulation of intercellular adhesion molecule-1 (ICAM-1) after
infection with H. pylori. Furthermore, we identify the
molecular mechanism of ICAM-1 gene activation following H. pylori infection in gastric epithelial cell cultures. These data
support the theory that the gastric epithelium plays an active role in
initiating inflammation as part of the host response to H. pylori infection.
Bacterial strains.
The H. pylori strain ATCC
49503 was used in most of this study. Other clinical strains (OHPC0001,
OHPC0002, and OHPC0003), isolated from chronic gastritis patients, were
kind gifts of T. Kitahora (Ohkura Hospital, Tokyo, Japan). The presence
of the cag pathogenicity island (PAI) and vacA in
these strains was determined by PCR using specific sets of primers
(1, 37). H. pylori strains were recovered from
frozen stocks by seeding them on a blood agar plate (Mueller-Hinton II
agar with 7% horse blood) at 37°C for 3 days under microaerophilic
conditions (10%, O2 and 10% CO2) generated
with Anaeropack Campylo (Mitsubishi Gas Chemicals Co., Tokyo, Japan).
Bacteria harvested from the plates by using cotton swabs were suspended
in 200 ml of brain heart infusion broth containing 10% fetal calf
serum and were then liquid-cultured at 37°C for 3 days with vigorous
shaking in a controlled microaerophilic atmosphere. Bacteria were
harvested from a broth culture by centrifugation and were resuspended
at the indicated concentrations in antibiotic-free medium. At this
time, bacteria reached a concentration of 4 × 108
CFU/ml. All procedures were performed with the approval of the respective institutional biosafety review committees and in compliance with their guidelines for biohazards.
Cell culture.
A panel of epithelial cell lines was cultured
in RPMI 1640 or Ham's F-12 medium supplemented with 10% fetal bovine
serum (GIBCO Laboratories, Grand Island, N.Y.) and antibiotics (50 U of
penicillin/ml and 50 µg of streptomycin/ml). In these experiments,
the gastric epithelial cancer cell lines MKN45, AGS, and KATO III were used.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Activation of Intercellular Adhesion Molecule 1 Expression by Helicobacter pylori Is Regulated by NF-
B in
Gastric Epithelial Cancer Cells
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
strain or H. pylori culture supernatants, resulted in
upregulation of steady-state mRNA levels and cell surface expression of
ICAM-1. Coculture with H. pylori induced an increase in
luciferase activity in cells which were transfected with a luciferase
reporter gene linked to the 5'-flanking region of the ICAM-1 gene.
H. pylori activated the ICAM-1 promoter via the NF-
B
binding site. An inducible nuclear protein complex bound to the ICAM-1
NF-
B site and was identified as the NF-
B p50-p65 heterodimer.
H. pylori induced the degradation of I
B-
, a major
cytoplasmic inhibitor of NF-
B, and stimulated the expression of
I
B-
mRNA. Pretreatment of epithelial cells with pyrrolidine
dithiocarbamate, which blocks NF-
B activation, inhibited H. pylori-induced ICAM-1 expression. THP-1 macrophagic cells,
peripheral blood mononuclear cells, and purified neutrophils adhered to
H. pylori-infected epithelial cells to a greater extent than to uninfected cells. These results show that H. pylori
directly induces expression of ICAM-1 on gastric epithelial cells in an NF-
B-dependent manner that may support leukocyte attachment during inflammation.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
(IL-1
), IL-6,
tumor necrosis factor alpha (TNF-
), and IL-8 compared to those in
specimens from uninfected individuals (9, 11, 13, 30).
Exposure of gastric epithelial cell lines to H. pylori
induced the secretion of a potent leukocyte chemotactic and activating
factor, IL-8 (19, 32). The association of IL-8 with H. pylori infection was further suggested by elevated levels of IL-8
in gastric epithelial cells in vivo (9), in tissue
homogenates of mucosal biopsy specimens (13, 27), and in in
vitro-cultured biopsy specimens from patients with H. pylori-associated gastritis and peptic ulcers (30).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Expression of ICAM-1.
To measure ICAM-1 expression on
epithelial cells after bacterial infection, epithelial-cell monolayers
were infected by adding H. pylori (final concentrations, 500 organisms/cell). Preliminary studies with MKN45 cells using varying
numbers of H. pylori organisms indicated that higher
concentrations of bacteria induced the death of epithelial cells, as
determined by morphological analysis. In the same series of
experiments, MKN45 cells were cocultured with culture supernatants from
H. pylori. In some experiments, MKN45 cells were treated
with pyrrolidine dithiocarbamate (PDTC; 20, 50, or 100 µM), which
inhibits NF-
B activation (5, 21, 28, 38). After 1 h
of PDTC exposure, the cells were infected with H. pylori.
For surface expression of ICAM-1, cells were harvested, washed, and
stained using the fluorescein isothiocyanate-conjugated mouse anti-CD54
monoclonal antibody (MAb) or the isotypic control immunoglobulin G1
(IgG1) (Coulter Immunology, Hialeah, Fla.). Fluorescence was measured
on a FACScan flow cytometer (Becton Dickinson, San Jose, Calif.).
Northern blot analysis.
Gastric epithelial cells were
cocultured with H. pylori for the indicated times. Total
cellular RNA was extracted from the cells using Trizol as described by
the manufacturer (GIBCO-BRL, Gaithersburg, Md.), and the amount of
total RNA was determined by measuring the absorbance at 260 nm. Twenty
micrograms of total RNA was electrophoresed on a formaldehyde-agarose
gel and was transferred onto a nylon filter. The filters were
prehybridized (0.5 M sodium phosphate-0.1% bovine serum albumin-7%
sodium dodecyl sulfate [SDS]-100 µg of salmon testis DNA/ml-100
µg of yeast RNA/ml) for 2 h at 65°C and then hybridized
overnight with the following [
-32P]dCTP radiolabeled
probes: cDNA of human ICAM-1 (kindly provided by T. K. Kishimoto,
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Conn.),
I
B-
(kindly provided by D. W. Ballard, Vanderbilt University
School of Medicine, Nashville, Tenn.) (15), and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (3).
Radiolabeled probes were generated using a Megaprime DNA Labeling
system (Amersham, Arlington Heights, Ill.).
Western blot analysis.
The antibody used for Western blot
analysis was a rabbit polyclonal antibody to I
B-
, C-21 (Santa
Cruz Biotechnology Inc., Santa Cruz, Calif.). Cells were lysed by
incubation in radioimmunoprecipitation assay buffer (0.5% sodium
deoxycholate, 1% Nonidet P-40, 0.1% SDS, 66 µg of aprotinin/ml, 100 µg of phenylmethylsulfonyl fluoride/ml, and 1 mM sodium
orthovanadate) for 30 min at 4°C. Equal amounts (50 µg) of protein
from cell lysates were electrophoresed on SDS-10% polyacrylamide gels
and transferred to polyvinylidine difluoride membranes. The membranes
were blocked with Tris-buffered saline-Tween (0.05%) containing 3%
nonfat dried milk overnight at 4°C, and then they were incubated for
45 min with a 1:500 dilution of the antibody. The membranes were washed
with Tris-buffered saline-Tween, incubated with a 1:1,000 dilution of
horseradish peroxidase-conjugated anti-rabbit immunoglobulin
(Amersham), and then developed using enhanced chemiluminescence
reagents (Amersham) and fluorography.
Luciferase assay.
The various ICAM-1 promoter constructs
have been described previously (25, 36). NF-
B-LUC is a
luciferase expression plasmid controlled by five copies of the IL-2
receptor (IL-2R)
chain gene
B element (a kind gift from J. Fujisawa, Kansai Medical University, Osaka, Japan) (34). For
the luciferase assay, 7 × 105 MKN45 cells were
transfected with 5 µg of each luciferase vector along with 0.1 µg
of pRL-TK, an internal control Renilla luciferase expression
vector (Toyo Ink Co., Tokyo, Japan), using the Calcium Phosphate
Mammalian Cell Transfection kit (5 Prime
3 Prime, Inc., Boulder,
Colo.) according to the manufacturer's recommendations. After 24 h, the transfected cells were divided into two parts, and H. pylori (final concentration, 500 organisms/cell) was added separately to each part. After an additional 6 h of incubation, cell lysates were prepared using PicaGene Dual (Toyo Ink Co.). Twenty
microliters of the cell lysates was assayed for both firefly and
Renilla luciferase activity using the dual-reporter assay system indicated above in a Lumat model LB9505C luminometer (Berthold, Bad Wildbad, Germany). The firefly luciferase activity was normalized to the Renilla luciferase activity, and the fold stimulation
was calculated as the ratio of the value for H. pylori-infected cells to that for uninfected cells.
Electrophoretic mobility shift assay (EMSA).
Nuclear
proteins were extracted from epithelial cells incubated in the presence
or absence of H. pylori (500 organisms/cell) as described by
Antalis and Godbolt (2) with modifications. Five-microgram
aliquots of nuclear proteins were incubated for 15 min at room
temperature with 1 ng of an [
-32P]dCTP- and
[
-32P]dATP-labeled NF-
B binding site of the ICAM-1
gene (5'-tcgaTAGCTTGGAAATTCCGGAGC-3'; lowercase letters indicate
residues added for labeling purposes) and 1 µg of poly(dI-dC)
(Pharmacia, Piscataway, N.J.) in 20 µl of a solution containing 10 mM
Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, and 5%
glycerol. In competition studies, a 100-fold excess of the unlabeled
ICAM-1
B probe, oligonucleotides containing a mutated NF-
B
binding site
(5'-tcgaTAGCTTCTAGATTAGGGAGC-3') (mutated sequences are underlined), or oligonucleotides bearing the IL-2R
chain gene NF-
B site
(5'-gatcCGGCAGGGGAATCTCCCTCTC-3') was included in the
reaction mixture along with the radiolabeled probe. In some
experiments, nuclear proteins were preincubated with 2 µg of
antibodies to p65, p50, p52, or c-Rel (Santa Cruz Biotechnology Inc.)
for 45 min at room temperature before addition of the labeled probe.
The mixtures were loaded onto a 4% polyacrylamide gel with 0.25×
Tris-borate buffer. After electrophoresis, gels were dried and analyzed
by autoradiography.
Adhesion assay. MKN45 cells were plated at confluent density (105 cells/well) in flat-bottom wells of a 96-well microtiter plate. THP-1 cells, PBMCs, or neutrophils were suspended in serum-free RPMI 1640 containing 5 µM 2', 7'-bis-(2-carboxyethyl-5)- and 2',7'-bis-(2-carboxyethyl-6)-carboxyfluorescein, acetoxymethyl ester (BCECF-AM) (Dojin Chemicals, Kumamoto, Japan). After incubation for 45 min at 37°C, these cells were washed with phosphate-buffered saline (PBS) and then resuspended in culture medium. Before adhesion experiments, cells either remained untreated or were incubated at 4°C for 1 h in the presence of either an anti-CD18 MAb, an anti-CD54 MAb, or control IgG1 (Immunotech, Marseille, France). Subsequently BCECF-labeled THP-1 cells (2 × 105 cells/well), PBMCs (106 cells/well), or neutrophils (106 cells/well) were deposited on unstimulated or H. pylori-stimulated MKN45 cell monolayers for 30 min at 37°C. Each experiment was run in quadruplicate. Nonadherent cells were removed by inverting the plates and washing with PBS. Adherent cells were solubilized with 1% Nonidet P-40 in PBS, and the fluorescence intensity of each well was measured with a Fluoroscan II (Labsystems, Helsinki, Finland).
| |
RESULTS |
|---|
|
|
|---|
H. pylori induces ICAM-1 expression in human gastric
epithelial cell lines.
We first examined the capacity of several
gastric epithelial cell lines to express ICAM-1 upon coculture with
live H. pylori. AGS and KATO III cells constitutively
expressed cell surface ICAM-1 and ICAM-1 mRNA, whereas MKN45 cells did
not (Fig. 1A and B; also data not shown).
Coculture with H. pylori significantly enhanced steady-state
levels of ICAM-1 mRNA in MKN45 cells and cell surface expression of
ICAM-1 by these cells (Fig. 1A and B). Similar results were also
obtained using AGS and KATO III cells (data not shown). Since the
H. pylori-induced ratio of enhancement of ICAM-1 expression was greatest on MKN45 cells, we used MKN45 cells in the following experiments. We next examined the dose dependency of H. pylori-induced ICAM-1 expression on MKN45 cells. The cell surface
expression of ICAM-1 was significantly increased after the addition of
0.5 H. pylori organism/cell (Fig. 1C). The highest level of
ICAM-1 expression was observed after infection with 50 H. pylori organisms/cell (Fig. 1C).
|
H. pylori strains differ in their abilities to induce
ICAM-1 expression.
Since recent studies indicated that expression
of multiple genes in the cag PAI is necessary for cytokine
production by gastric epithelial cells in vitro (6, 35), we
examined the abilities of several H. pylori strains to
induce ICAM-1 expression. All isolates were positive for
vacA (1) irrespective of ability to induce ICAM-1
expression (Fig. 2). Strain OHPC0002,
which totally lacked the cag PAI, induced ICAM-1
mRNA and cell surface expression at levels considerably lower than
those of strains ATCC 49503, OHPC0001, and OHPC0003, containing the
entire cag PAI (37) (Fig. 2). These results
suggest that the H. pylori cag PAI may play an important
role in the induction of ICAM-1 expression, which parallels a
previously reported observation on IL-8 expression (6, 35).
|
Activation of the ICAM-1 promoter by H. pylori.
To
confirm that H. pylori-induced ICAM-1 upregulation occurred
by activating gene transcription, the ICAM-1 5'-flanking region was
analyzed with promoter/reporter gene constructs. MKN45 cells were
transiently transfected with a plasmid, pBHluc1.3, which contains 1,344 bp of the ICAM-1 upstream region (
1,353 to
9 relative to the start
of transcription), directing expression of the firefly luciferase
reporter gene, and the transfected cells were then stimulated with
H. pylori. Stimulation of MKN45 cells with H. pylori resulted in a 6.6-fold increase in luciferase activity, whereas the negative-control vector, pBHlucOL1, showed only low background activity (Fig. 3B). Strains
OHPC0001 and OHPC0003 induced ICAM-1 promoter activity to similar
levels. However, strain OHPC0002, devoid of cag PAI, and
H. pylori ATCC 49503 culture supernatants were not found to
increase ICAM-1 promoter activity (data not shown). These results
indicated that the interaction with H. pylori induces ICAM-1
expression on MKN45 cells at the level of transcription.
|
941 and the smallest beginning with bp
136) into MKN45 cells (Fig. 3A). High levels of induction were
observed with the reporter constructs containing ICAM-1 5'-flanking
sequence starting with position
1,353 (pBHluc1.3) to position
353
(construct D). However, further deletion to
136 (construct E)
resulted in a complete loss of H. pylori-induced promoter
activity. It was apparent that the ICAM-1 5'-flanking sequence between
353 and
136 was required for the promoter to respond to H. pylori. To further investigate this H. pylori-responsive region, the sequence spanning bp
445 to
289
was cloned into construct E, resulting in construct P. This was not
induced by H. pylori. Therefore, we concluded that the
region of the ICAM-1 promoter most critical for H. pylori
induction in gastric epithelial cells was located between
289 and
136.
Sequence analysis of the H. pylori-responsive region between
289 and
136 revealed potential binding sites for five transcription factors, AP-1 (
284 to
278), Sp1 (
206 to
201), C/EBP (
199 to
196), Ets (
153 to
150), and NF-
B (
187 to
178). Hou et al.
(18) and Ledebur and Parks (25) demonstrated that
TNF-
-induced activation of the ICAM-1 promoter required the NF-
B
site. In order to determine the functional importance of the NF-
B
site, transient transfections with mutant ICAM-1 promoter/luciferase reporter gene constructs with specific mutations in either the NF-
B
(designated pGL1.3
B
) or the Ets (designated
pGL1.3Ets
) binding site (25) were performed
(Fig. 3C). Mutation of the NF-
B site in the ICAM-1 promoter
significantly reduced H. pylori-mediated luciferase activity
in gastric cells, whereas the Ets site mutation had no effect (Fig.
3D). These experiments indicated that activation of the ICAM-1 promoter
in MKN45 cells in response to H. pylori stimulation required
an intact binding site for NF-
B.
Stimulation with H. pylori induces a single predominant
B binding complex.
Transient transfection experiments with
wild-type and mutant ICAM-1 promoter/luciferase reporter gene
constructs indicated that the NF-
B site is essential for activation
by H. pylori in MKN45 cells. To determine whether the
increase in ICAM-1 expression seen in H. pylori-stimulated
gastric epithelial cells was related to an alteration of NF-
B DNA
binding activity, nuclear extracts from gastric epithelial cells were
prepared, and EMSA was performed using the ICAM-1 promoter NF-
B
element as a probe. Figure 4A shows the
results for MKN45 cell nuclear extracts. Control MKN45 cell nuclear
extracts contained little activated NF-
B (Fig. 4A, lane 1). A single
B binding complex was observed in MKN45 cells after stimulation with
H. pylori (Fig. 4A). Infection of KATO III and AGS cells
with H. pylori resulted in NF-
B activation similar to
that observed in MKN45 cells (data not shown). NF-
B activation was
first evident at 30 min (Fig. 4A, lane 3) and appeared to be maximal at
1 h after H. pylori infection (Fig. 4A, lane 4). The
levels of active NF-
B in nuclear extracts prepared from MKN45 cells
after 2 h of exposure to H. pylori culture supernatants were similar to those in the control (data not shown). The specificity of this inducible
B-binding factor was confirmed by competition analysis with unlabeled oligonucleotides containing the ICAM-1 NF-
B
site, the IL-2R
gene NF-
B site, or an ICAM-1 NF-
B site with a
point mutation. NF-
B proteins appeared to mediate this H. pylori-induced binding, since unlabeled wild-type ICAM-1 (Fig. 4B,
lane 3) or IL-2R
B (lane 4), but not a mutant
B
oligonucleotide (lane 5), effectively competed for binding to the
NF-
B complex.
|
B DNA binding complex,
antibodies to NF-
B family members p65, c-Rel, p50, and p52 were
preincubated with the nuclear extracts from MKN45 cells and used in
supershift analysis (Fig. 4C). Anti-p65 specifically recognized the
stimulated
B-DNA binding complex, resulting in supershifted
complexes (Fig. 4C, lane 4). Preincubation with anti-c-Rel or anti-p52
did not affect the
B binding complex (Fig. 4C, lanes 5 and 6), but
preincubation with anti-p50 resulted in the formation of a partially
supershifted complex (Fig. 4C, lane 3). These results suggest that in
MKN45 cells, an NF-
B p65-p50 heterodimer, and possibly a p65
homodimer, is rapidly induced in response to H. pylori infection.
The NF-
B site is sufficient to mediate cag
PAI+ strain-induced gene activation.
Since it has been
previously shown that cag PAI+ strains induce
significantly more IL-8 mRNA and protein than do cag
PAI
strains (8, 10, 32), we sought to
ascertain whether the difference between the abilities of different
H. pylori strains to induce ICAM-1 expression was related to
their abilities to activate NF-
B (Fig.
5A). NF-
B DNA binding activity was
markedly induced by cag PAI+ H. pylori strains (Fig. 5A, lanes 2, 3, and 5) compared to the cag PAI
strain (lane 4).
|
B site was sufficient for
activation by H. pylori, a reporter construct driven by an NF-
B element was compared (Fig. 5B). The construct
B-LUC, which contains five tandem repeats of the NF-
B site, was markedly
stimulated by cag PAI+ H. pylori
strains, whereas infection of MKN45 cells with a cag PAI
strain resulted in only a slight increase in reporter
activity (Fig. 5B). These results demonstrate that the NF-
B site is
sufficient for cag PAI-specific activation of H. pylori-induced ICAM-1 gene expression.
Degradation of I
B-
by H. pylori.
Since
signal-induced proteolytic degradation of I
B-
precedes the
appearance of NF-
B DNA binding activity, we determined whether
I
B-
was degraded in MKN45 cells that were stimulated by H. pylori. Kinetic analysis of H. pylori-induced
degradation of I
B-
in MKN45 cells revealed a delayed loss of
I
B-
which was maximal at 30 min, followed by restoration of
I
B-
levels to those of unstimulated MKN45 cells after 3 h of
culture (Fig. 6A).
|
Induction of I
B-
mRNA expression in MKN45 cells by H. pylori.
It is possible that H. pylori suppressed the
transcription of the I
B-
gene. It has been reported that
transcription of the I
B-
gene is regulated by the NF-
B binding
site in the promoter and is activated by NF-
B p65 or c-Rel as part
of a negative feedback loop (24). To examine whether
H. pylori induces I
B-
, we carried out Northern
analysis on I
B-
mRNA from MKN45 cells stimulated with H. pylori. MKN45 cells were cultured with H. pylori or in medium alone, and total RNA was extracted at 1, 2, 6, and 24 h. Induction of I
B-
mRNA by H. pylori was observed at
1 h and was maximal at 2 h, decreasing thereafter (Fig. 6B).
These results clearly indicate that the decrease in I
B-
protein
induced by H. pylori resulted not from suppression of
transcription but from modulation of posttranscriptional events,
probably at the protein level. Cumulatively, these results indicate
that H. pylori activates MKN45 cells, as reflected by a loss
of I
B-
protein and upregulation of its mRNA.
Inhibition of NF-
B activation reduces ICAM-1 expression in
response to H. pylori infection.
PDTC potently
inhibits NF-
B activation and/or NF-
B interaction with its
upstream regulatory binding site, thereby preventing NF-
B-mediated
transcriptional activation (5, 21, 28, 38). We used PDTC to
show a link between NF-
B activation and upregulation of ICAM-1
expression in H. pylori-infected MKN45 cells. As shown in
Fig. 7, PDTC treatment markedly inhibited
H. pylori-induced cell surface expression of ICAM-1 (92%
inhibition by 100 µM PDTC). However, PDTC had no effect on the
viability of MKN45 cells (data not shown).
|
H. pylori infection of epithelial cells increases
leukocyte adhesion.
MKN45 cells were infected for 6 h with
H. pylori. THP-1 cells, PBMCs, or purified neutrophils were
used as leukocytes for adhesion experiments. The cells were
fluorescently labeled and added to uninfected or 6-h-H.
pylori-infected MKN45 cells, and after 30 min, the adherence of
the leukocytes was measured. As shown in Fig.
8A, H. pylori significantly
increased the adhesion of THP-1 cells, PBMCs, and purified neutrophils
to MKN45 cells (11.8-, 5.8-, and 5.8-fold, respectively) compared with
adhesion to MKN45 cells cultured in medium alone. Neutrophils were
treated with an anti-CD18 MAb, an anti-CD54 MAb, or a control IgG1
before addition to H. pylori-infected MKN45 cells, and the
amount of adhesive cells was measured under these conditions. As shown
in Fig. 8B, the anti-CD18 MAb and the anti-CD54 MAb significantly decreased the adhesion of neutrophils to H. pylori-infected
MKN45 cells, whereas the control IgG1 did not.
|
| |
DISCUSSION |
|---|
|
|
|---|
ICAM-1 is one of several cell adhesion molecules that belong to
the immunoglobulin superfamily and serve as ligands for the
2 integrins, lymphocyte function-associated antigen-1
(LFA-1, also referred to as CD11a/CD18), and Mac-1 (CD11b/CD18). In
contrast to LFA-1, which is constitutively expressed on leukocytes,
ICAM-1 is an inducible cell surface glycoprotein expressed at a low
level on a wide variety of cells, including leukocytes, vascular
endothelium, fibroblasts, and certain epithelial cells. However, ICAM-1
expression is dramatically increased at sites of inflammation,
providing important means of regulating cell-cell interactions and
thereby presumably inflammatory responses. The function and indeed the importance of leukocyte adhesion in the generation and maintenance of
inflammation have been demonstrated in numerous animal experimental systems using blocking MAbs directed against ICAM-1 as well as ICAM-1
knockout mice.
Researchers in several laboratories have demonstrated the expression of ICAM-1 in chronic gastritis associated with H. pylori in vivo (12, 16, 17). However, the mechanism whereby H. pylori induces the expression of ICAM-1 remains largely unknown. This study was therefore designed to evaluate ICAM-1 expression on gastric epithelial cells exposed to H. pylori in vitro.
First, we observed that H. pylori stimulated significant
increases in steady-state mRNA levels and cell surface expression of
ICAM-1 in gastric epithelial cells. Next, we investigated the molecular
mechanisms by which ICAM-1 gene expression is regulated upon the
exposure of gastric epithelial cells to H. pylori strains. TNF-
- and gamma interferon (IFN-
)-induced activation of ICAM-1 have been reported to require different transcription factors. Hou et
al. (18) and Ledebur and Parks (25) demonstrated
that TNF-
-induced activation of the ICAM-1 promoter required a
variant NF-
B site, 178 to 187 nucleotides upstream of the
transcription start site. In contrast, Look and coworkers
(26) demonstrated that the IFN-
response element located
at nucleotides
76 to
66 of the ICAM-1 5'-flanking region conferred
IFN-
responsiveness. The IFN-
-induced DNA binding complex
contained STAT1
(18). The data presented here indicate
that the NF-
B binding sequence in the ICAM-1 promoter is required
for H. pylori-induced ICAM-1 upregulation, whereas the
IFN-
response element was not essential.
cag PAI+ strains, unlike cag
PAI
strains, provoke potentially damaging inflammatory
responses in infected host tissue and induce the synthesis of IL-8 in
gastric biopsy specimens and cultured cells (8, 10, 32). Our
study shows that the NF-
B p50-p65 heterodimer is activated in
gastric epithelial cells in response to PAI+ strains of
H. pylori. Compared to a cag PAI
H. pylori strain, the more-virulent cag
PAI+ strains showed an enhanced ability to induce NF-
B
binding activity, paralleling observations that increased ICAM-1
induction in MKN45 cells was cag PAI+ strain
specific. Along these lines, increased IL-8 expression in epithelial
cells in response to cag PAI+ H. pylori strains may result from increased NF-
B binding to the
IL-8 promoter (33). H. pylori infection of the
gastric epithelium, therefore, utilizes similar mechanisms to regulate
the orchestrated production of ICAM-1 and IL-8.
Like many other NF-
B activators, H. pylori induced the
degradation of I
B-
in gastric epithelial cells. Degradation of
I
B-
in H. pylori-induced epithelial cells was
associated with translocation of NF-
B and increased levels of
I
B-
mRNA. Activated NF-
B was evident within 30 min of
bacterial infection and was pronounced at 1 h. These findings are
consistent with the NF-
B activation observed in H. pylori-infected epithelial cells before ICAM-1 mRNA levels are
increased, followed in turn by increased cell surface ICAM-1
expression. Furthermore, the blocking of NF-
B activation by PDTC
markedly inhibited cell surface ICAM-1 expression after H. pylori infection. These findings suggest that NF-
B activation may be a necessary prerequisite for increased epithelial-cell ICAM-1
expression in response to bacterial infection by H. pylori.
Our experiments using cell-free H. pylori culture
supernatants suggest that the activation of ICAM-1 expression in
gastric epithelial cells might not be mediated by a soluble product
released from the bacterium. Other investigators have reported that
direct contact with live H. pylori is indispensable for IL-8
production by gastric epithelial cells (1, 22). Expression
of ICAM-1 was upregulated in vitro by inflammatory cytokines, including IL-1 and TNF-
(20, 23, 25, 36). These inflammatory
cytokines increase in the gastric mucosa of patients with chronic
gastritis associated with H. pylori. Therefore, these
cytokines produced in response to H. pylori infection may
participate in the expression of this cell adhesion molecule. However,
H. pylori could not induce the production of IL-1 or TNF-
by MKN45 cells (data not shown). Thus, gastric epithelial cells
expressed ICAM-1 only through direct infection with H. pylori in vitro.
The finding that H. pylori is a potent activator of NF-
B
has important implications, since other NF-
B-responsive genes, including those encoding IL-8, TNF-
, IL-1, and IL-6, have been found
to be elevated in the gastric mucosa of persons with H. pylori (9, 11, 13, 30). H. pylori-induced
NF-
B activation and the subsequent upregulation of ICAM-1 and
cytokines could contribute to inflammatory-cell recruitment and
retention at sites of infection. Because of its pivotal role in
inflammation, NF-
B will be an obvious target for new types of
anti-inflammatory treatments for H. pylori-induced
gastritis. Blocking the activation of NF-
B, as by use of PDTC, may
prevent the early events in the inflammatory cascade, decreasing
H. pylori-induced inflammation and subsequent gastric injury.
In conclusion, we showed that H. pylori is able to directly induce epithelial ICAM-1 expression, which mediates the adhesion of leukocytes to epithelium and may be important in the initiation and maintenance of gastric inflammation in H. pylori gastritis.
| |
ACKNOWLEDGMENTS |
|---|
The expert technical assistance of M. Yamamoto and M. Sasaki is gratefully acknowledged. We thank T. Kitahora for providing several clinical isolates of H. pylori, and we thank J. Fujisawa, T. K. Kishimoto, and D. W. Ballard for providing plasmids.
This work was supported in part by a Grant-in-Aid for Encouragement of Young Scientists from the Ministry of Education, Science, Sports and Culture of Japan and by the Uehara Memorial Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Preventive Medicine and AIDS Research, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan. Phone: 81-95-849-7846. Fax: 81-95-849-7805. E-mail: n-mori{at}net.nagasaki-u.ac.jp.
Editor: J. D. Clements
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aihara, M., D. Tsuchimoto, H. Takizawa, A. Azuma, H. Wakebe, Y. Ohmoto, K. Imagawa, M. Kikuchi, N. Mukaida, and K. Matsushima. 1997. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect. Immun. 65:3218-3224[Abstract]. |
| 2. |
Antalis, T. M., and D. Godbolt.
1991.
Isolation nuclei from hematopoietic cell types.
Nucleic Acids Res.
19:4301 |
| 3. | Benham, F. J., S. Hodgkinson, and K. E. Davies. 1984. A glyceraldehyde-3-phosphate dehydrogenase pseudogene on the short arm of the human X chromosomes defines a multigene family. EMBO J. 3:2635-2640[Medline]. |
| 4. | Blaser, M. J. 1992. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102:720-727[Medline]. |
| 5. |
Brennan, P., and L. A. O'Neill.
1996.
2-Mercaptoethanol restores the ability of nuclear factor B (NF- B) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrrolidine dithiocarbamate (PDTC). Evidence for oxidation of glutathione in the mechanism of inhibition of NF- B by PDTC.
Biochem. J.
320:975-981.
|
| 6. |
Censini, S.,
C. Lange,
Z. Xiang,
J. E. Crabtree,
P. Ghiara,
M. Borodovsky,
R. Rappuoli, and A. Covacci.
1996.
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.
Proc. Natl. Acad. Sci. USA
93:14648-14653 |
| 7. | Cover, T. L., and M. J. Blaser. 1992. Helicobacter pylori and gastroduodenal disease. Annu. Rev. Med. 43:135-145[CrossRef][Medline]. |
| 8. |
Crabtree, J. E.,
A. Covacci,
S. M. Farmery,
Z. Xiang,
D. S. Tompkins,
S. Perry,
I. J. D. Lindley, and R. Rappuoli.
1995.
Helicobacter pylori-induced interleukin-8 expression in gastric epithelial cells is associated with CagA-positive phenotype.
J. Clin. Pathol.
48:41-45 |
| 9. |
Crabtree, J. E.,
J. I. Wyatt,
L. K. Trejdosiewicz,
P. Peichl,
P. H. Nichols,
N. Ramsay,
J. N. Primrose, and I. J. D. Lindley.
1994.
Interleukin-8 expression in Helicobacter pylori-infected, normal, and neoplastic gastroduodenal mucosa.
J. Clin. Pathol.
47:61-66 |
| 10. |
Crabtree, J. E.,
S. M. Farmery,
I. J. D. Lindley,
N. Figura,
P. Peichl, and D. S. Tompkins.
1994.
CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines.
J. Clin. Pathol.
47:945-950 |
| 11. |
Crabtree, J. E.,
T. M. Shallcross,
R. V. Heatley, and J. I. Wyatt.
1991.
Mucosal tumour necrosis factor and interleukin-6 in patients with Helicobacter pylori-associated gastritis.
Gut
32:1473-1477 |
| 12. | El Kaissouni, J., M. C. Bene, and G. C. Faure. 1998. Activation of epithelial cells in gastritis. Digestion 59:53-59[CrossRef][Medline]. |
| 13. | Gionchetti, P., D. Vaira, M. Campieri, J. Holton, M. Menegatti, A. Belluzzi, E. Bertinelli, M. Ferretti, C. Brignola, M. Miglioli, and L. Barbara. 1994. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am. J. Gastroenterol. 89:883-887[Medline]. |
| 14. | Graham, D. Y. 1992. Pathogenic mechanisms leading to Helicobacter pylori-induced inflammation. Eur. J. Gastroenterol. Hepatol. 4:S9-S16. |
| 15. |
Haskill, S.,
A. A. Beg,
S. M. Tompkins,
J. S. Morris,
A. D. Yurochko,
A. Sampson-Johannes,
K. Mondal,
P. Ralph, and A. S. Baldwin, Jr.
1991.
Characterization of an immediate-early gene induced in adherent monocytes that encodes I B-like activity.
Cell
65:1281-1289[CrossRef][Medline].
|
| 16. | Hatz, R. A., G. Rieder, M. Stolte, E. Bayerdorffer, G. Meimarakis, F.-W. Schildberg, and G. Enders. 1997. Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology 112:1908-1919[CrossRef][Medline]. |
| 17. | Higuchi, K., T. Arakawa, T. Uchida, K. Nakagawa, S. Nakamura, T. Matsumoto, T. Fukuda, K. Kobayashi, and T. Kuroki. 1997. In situ expression of cell adhesion molecules in chronic gastritis with Helicobacter pylori infection. J. Clin. Gastroenterol. 25:S215-S221. |
| 18. |
Hou, J.,
V. Baichwal, and Z. Cao.
1994.
Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1.
Proc. Natl. Acad. Sci. USA
91:11641-11645 |
| 19. | Huang, J., P. W. O'Toole, P. Doig, and T. J. Trust. 1995. Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect. Immun. 63:1732-1738[Abstract]. |
| 20. | Kaiserlian, D., D. Rigal, J. Abello, and J. P. Revillard. 1991. Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur. J. Immunol. 21:2415-2421[Medline]. |
| 21. | Kawai, M., R. Nishikomori, E. Y. Jung, G. Tai, C. Yamanaka, M. Mayumi, and T. Heike. 1995. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. J. Immunol. 154:2333-2341[Abstract]. |
| 22. |
Keates, S.,
Y. S. Hitti,
M. Upton, and C. P. Kelly.
1997.
Helicobacter pylori infection activates NF- B in gastric epithelial cells.
Gastroenterology
113:1099-1109[CrossRef][Medline].
|
| 23. | Kvale, D., P. Krajci, and P. Brandtzaeg. 1992. Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand. J. Immunol. 35:669-676[CrossRef][Medline]. |
| 24. |
Le Bail, O.,
R. Schmidt-Ullrich, and A. Israel.
1993.
Promoter analysis of the gene encoding the I B- /MAD3 inhibitor of NF- B: positive regulation by members of the rel/NF- B family.
EMBO J.
12:5043-5049[Medline].
|
| 25. |
Ledebur, H. C., and T. P. Parks.
1995.
Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF- B site and p65 homodimers.
J. Biol. Chem.
270:933-943 |
| 26. |
Look, D. C.,
M. R. Pelletier, and M. J. Holtzman.
1994.
Selective interaction of a subset of interferon- response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells.
J. Biol. Chem.
269:8952-8958 |
| 27. |
Moss, S. F.,
S. Legon,
J. Davies, and J. Calam.
1994.
Cytokine gene expression in Helicobacter pylori-associated antral gastritis.
Gut
35:1567-1570 |
| 28. |
Munoz, C.,
D. Pascual-Salcedo,
M. C. Castellanos,
A. Alfranca,
J. Aragones,
A. Vara,
M. J. Redondo, and M. O. de Landazuri.
1996.
Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF- B and AP-1 transcription factors activity.
Blood
88:3482-3490 |
| 29. | NIH Consensus Conference. 1994. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272:65-69[CrossRef][Medline]. |
| 30. |
Noach, L. A.,
N. B. Bosma,
J. Jansen,
F. J. Hoek,
S. J. H. van Deventer, and G. N. J. Tytgat.
1994.
Mucosal tumor necrosis factor- , interleukin-1 , and interleukin-8 production in patients with Helicobacter pylori infection.
Scand. J. Gastroenterol.
29:425-429[Medline].
|
| 31. | Nomura, A., G. N. Stemmermann, P. H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser. 1991. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325:1132-1136[Abstract]. |
| 32. | Sharma, S. A., M. K. R. Tummuru, G. G. Miller, and M. J. Blaser. 1995. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect. Immun. 63:1681-1687[Abstract]. |
| 33. |
Sharma, S. A.,
M. K. R. Tummuru,
M. J. Blaser, and L. D. Kerr.
1998.
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor- B in gastric epithelial cells.
J. Immunol.
160:2401-2407 |
| 34. |
Suzuki, T.,
H. Hirai,
T. Murakami, and M. Yoshida.
1995.
Tax protein of HTLV-1 destabilizes the complexes of NF- B and I B- and induces nuclear translocation of NF- B for transcriptional activation.
Oncogene
10:1199-1207[Medline].
|
| 35. | Tummuru, M. K. R., S. A. Sharma, and M. J. Blaser. 1995. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 18:867-876[CrossRef][Medline]. |
| 36. |
Voraberger, G.,
R. Schafer, and C. Stratowa.
1991.
Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester.
J. Immunol.
147:2777-2786 |
| 37. |
Wada, A.,
N. Mori,
K. Oishi,
H. Hojo,
Y. Nakahara,
Y. Hamanaka,
M. Nagashima,
I. Sekine,
K. Ogushi,
T. Niidome,
T. Nagatake,
J. Moss, and T. Hirayama.
1999.
Induction of human -defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island.
Biochem. Biophys. Res. Commun.
263:770-774[CrossRef][Medline].
|
| 38. |
Ziegler-Heitbrock, H. W.,
T. Sternsdorf,
J. Liese,
B. Belohradsky,
C. Weber,
A. Wedel,
R. Schreck,
P. Bauerle, and M. Strobel.
1993.
Pyrrolidine dithiocarbamate inhibits NF- B mobilization and TNF production in human monocytes.
J. Immunol.
151:6986-6993[Abstract].
|
This article has been cited by other articles:
| ||||||||||